Clinical anticancer pharmacology: some pharmacokinetic considerations.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000912:Antibodies, Neoplasm / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D001711:Biotransformation; D006801:Humans; D007263:Infusions, Parenteral; D007269:Injections, Intra-Arterial; D007276:Injections, Intraventricular; D007278:Injections, Spinal; D007700:Kinetics; D008081:Liposomes / Q000008:administration & dosage; D008657:Metabolic Clearance Rate; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D014677:Pharmaceutical Vehicles
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D008081:Liposomes; D014677:Pharmaceutical Vehicles